These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

137 related articles for article (PubMed ID: 20828739)

  • 1. Predicting the prognosis of hepatocellular carcinoma using gene expression.
    Chang SH; Suh KS; Yi NJ; Lee KH; Kim BY; Jang JJ
    J Surg Res; 2011 Dec; 171(2):524-31. PubMed ID: 20828739
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluation of predictive value of CLIP, Okuda, TNM and JIS staging systems for hepatocellular carcinoma patients undergoing surgery.
    Huang YH; Chen CH; Chang TT; Chen SC; Wang SY; Lee HS; Lin PW; Huang GT; Sheu JC; Tsai HM; Lee PC; Chau GY; Lui WY; Lee SD; Wu JC
    J Gastroenterol Hepatol; 2005 May; 20(5):765-71. PubMed ID: 15853992
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Prognostic value of CLIP score system for patients with resection of hepatocellular carcinoma].
    Zhao W; Ma Z; Zhou X; Feng Y; Fang B
    Zhonghua Wai Ke Za Zhi; 2002 May; 40(5):321-5. PubMed ID: 12133332
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Operative blood loss independently predicts recurrence and survival after resection of hepatocellular carcinoma.
    Katz SC; Shia J; Liau KH; Gonen M; Ruo L; Jarnagin WR; Fong Y; D'Angelica MI; Blumgart LH; Dematteo RP
    Ann Surg; 2009 Apr; 249(4):617-23. PubMed ID: 19300227
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognosis and survival analysis according to seven staging systems of hepatocellular carcinoma following curative resection.
    Choi SB; Lee JG; Kim KS; Yoon DS; Choi JS; Lee WJ; Kim BR
    Hepatogastroenterology; 2008; 55(88):2140-5. PubMed ID: 19260493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Integrated analysis of prognostic gene expression profiles from hepatitis B virus-positive hepatocellular carcinoma and adjacent liver tissue.
    Kim BY; Suh KS; Lee JG; Woo SR; Park IC; Park SH; Han CJ; Kim SB; Jeong SH; Yeom YI; Yang SJ; Kim CM; Cho SJ; Yoo YD; Cho MH; Jang JJ; Choi DW; Lee KH
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S328-38. PubMed ID: 21533656
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Predictors and patterns of recurrence after resection of hepatocellular carcinoma.
    Cha C; Fong Y; Jarnagin WR; Blumgart LH; DeMatteo RP
    J Am Coll Surg; 2003 Nov; 197(5):753-8. PubMed ID: 14585409
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Overexpression of galectin-1 is associated with poor prognosis in human hepatocellular carcinoma following resection.
    Wu H; Chen P; Liao R; Li YW; Yi Y; Wang JX; Sun TW; Zhou J; Shi YH; Yang XR; Jin JJ; Cheng YF; Fan J; Qiu SJ
    J Gastroenterol Hepatol; 2012 Aug; 27(8):1312-9. PubMed ID: 22432916
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic factors affecting survival after recurrence in adult living donor liver transplantation for hepatocellular carcinoma.
    Shin WY; Suh KS; Lee HW; Kim J; Kim T; Yi NJ; Lee KU
    Liver Transpl; 2010 May; 16(5):678-84. PubMed ID: 20440777
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence and poor prognosis following resection of small hepatitis B-related hepatocellular carcinoma lesions are associated with aberrant tumor expression profiles of glypican 3 and osteopontin.
    Yu MC; Lee YS; Lin SE; Wu HY; Chen TC; Lee WC; Chen MF; Tsai CN
    Ann Surg Oncol; 2012 Jul; 19 Suppl 3():S455-63. PubMed ID: 21822558
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Impact of histological grade of hepatocellular carcinoma on the outcome of liver transplantation.
    Tamura S; Kato T; Berho M; Misiakos EP; O'Brien C; Reddy KR; Nery JR; Burke GW; Schiff ER; Miller J; Tzakis AG
    Arch Surg; 2001 Jan; 136(1):25-30; discussion 31. PubMed ID: 11146770
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A gene expression profile for vascular invasion can predict the recurrence after resection of hepatocellular carcinoma: a microarray approach.
    Ho MC; Lin JJ; Chen CN; Chen CC; Lee H; Yang CY; Ni YH; Chang KJ; Hsu HC; Hsieh FJ; Lee PH
    Ann Surg Oncol; 2006 Nov; 13(11):1474-84. PubMed ID: 17009164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Prognosis of hepatocellular carcinoma according to new staging classifications].
    Caselitz M; Masche N; Flemming P; Stern C; Manns MP; Wagner S; Kubicka S
    Dtsch Med Wochenschr; 2004 Aug; 129(33):1725-30. PubMed ID: 15295682
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Liver transplantation for patients with hepatocellular carcinoma at the Liver Cancer Institute of Fudan University, China.
    Zhou J; Fan J; Wu ZQ; Qiu SJ; Huang XW; Yu Y; Wang Z; Sun J; Xiao YS; He YF; Yang GH; Song K; Yuan Z; Wang YQ; Tang ZY
    Chin Med J (Engl); 2005 Apr; 118(8):654-9. PubMed ID: 15899120
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Osteopontin, a single marker for predicting the prognosis of patients with tumor-node-metastasis stage I hepatocellular carcinoma after surgical resection.
    Chen RX; Xia YH; Cui JF; Xue TC; Ye SL
    J Gastroenterol Hepatol; 2010 Aug; 25(8):1435-42. PubMed ID: 20659235
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Evaluation of predictive value of Okuda, TNM, CLIP and JIS staging systems for hepatocellular carcinoma patients].
    Lee SW; Han SY; Kim KT; Baek YH; Koh IY; Kim BH; Park EH; Jang JS; Roh MH; Choi JC
    Korean J Hepatol; 2007 Jun; 13(2):196-207. PubMed ID: 17585193
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Cytokeratin 10 and cytokeratin 19: predictive markers for poor prognosis in hepatocellular carcinoma patients after curative resection.
    Yang XR; Xu Y; Shi GM; Fan J; Zhou J; Ji Y; Sun HC; Qiu SJ; Yu B; Gao Q; He YZ; Qin WZ; Chen RX; Yang GH; Wu B; Lu Q; Wu ZQ; Tang ZY
    Clin Cancer Res; 2008 Jun; 14(12):3850-9. PubMed ID: 18559605
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemoembolization for hepatocellular carcinoma: multivariate analysis of predicting factors for tumor response and survival in a 362-patient cohort.
    Hu HT; Kim JH; Lee LS; Kim KA; Ko GY; Yoon HK; Sung KB; Gwon DI; Shin JH; Song HY
    J Vasc Interv Radiol; 2011 Jul; 22(7):917-23. PubMed ID: 21571545
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Molecular prediction of early recurrence after resection of hepatocellular carcinoma.
    Yoshioka S; Takemasa I; Nagano H; Kittaka N; Noda T; Wada H; Kobayashi S; Marubashi S; Takeda Y; Umeshita K; Dono K; Matsubara K; Monden M
    Eur J Cancer; 2009 Mar; 45(5):881-9. PubMed ID: 19167881
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Risk factors for early recurrence after surgical resection for hepatocellular carcinoma].
    Park UJ; Kim YH; Kang KJ; Lim TJ
    Korean J Hepatol; 2008 Sep; 14(3):371-80. PubMed ID: 18815460
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.